Antihemophilic factor/von Willebrand factor (CSL Behring)

N/A

Report date: 2024/09/20 14:07:17

Base Information

Drug NameAntihemophilic factor/von Willebrand factor (CSL Behring)
Drug Alias NameFactor VIII/von Willebrand factor (CSL Behring)凝血因子VIII (CSL Behring)Antihemophilic Factor/von Willebrand Factor Complex (Human)血管性血友病 (CSL Behring)Aleviate +[9] 
ClassificationBiologics > Protein drugs > Non-recombinant coagulation factorBiologics > Blood components > Non-recombinant coagulation factor
Mechanisms of ActionCoagulation factor VIII replacementsCoagulation factor X stimulantsVon willebrand factor replacements +[4] 
TargetsCoagulation factor VIIICoagulation factor X
Therapy Area/Indicationsvon Willebrand DiseasesHemophilia A
Global Approved Indicationsvon Willebrand DiseasesHemophilia A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1999/04/01
Country/TerritoryBulgariaUnited StatesUkraine +[16] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesCsl Behring Llc
China Registration ClassN/A

Develop Information

Active CompaniesCsl Behring Gmbh
Inactive CompaniesCsl Behring
Active Indicationsvon Willebrand DiseasesHemophilia A
Inactive IndicationsN/A

Other Information

ATC CodeB02BD06
Related LinksN/A